Judit Dobos, Dr.
Affiliations: | 2007 | Semmelweis Egyetem, Hungary |
Area:
Oncology, Cell BiologyGoogle:
"Judit Dobos"Parents
Sign in to add mentor| Andrea Ladanyi | grad student | 2007 | Semmelweis Egyetem | |
| (A melanoma progressziojat befolyasolo endokrin tenyezők.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Nelhűbel GA, Cserepes M, Szabó B, et al. (2021) EGFR Alterations Influence the Cetuximab Treatment Response and c-MET Tyrosine-Kinase Inhibitor Sensitivity in Experimental Head and Neck Squamous Cell Carcinomas. Pathology Oncology Research : Por. 27: 620256 |
| Baska F, Sipos A, Őrfi Z, et al. (2019) Discovery and development of extreme selective inhibitors of the ITD and D835Y mutant FLT3 kinases. European Journal of Medicinal Chemistry. 184: 111710 |
| Zsákai L, Sipos A, Dobos J, et al. (2019) Targeted drug combination therapy design based on driver genes. Oncotarget. 10: 5255-5266 |
| Kenessey I, Kramer Z, István L, et al. (2018) Inhibition of epidermal growth factor receptor improves antitumor efficacy of vemurafenib in BRAF-mutant human melanoma in preclinical model. Melanoma Research |
| Nemes Z, Takács-Novák K, Völgyi G, et al. (2018) Synthesis and characterization of amino acid substituted sunitinib analogues for the treatment of AML. Bioorganic & Medicinal Chemistry Letters |
| Czudor Z, Balogh M, Bánhegyi P, et al. (2018) Novel compounds with potent CDK9 inhibitory activity for the treatment of myeloma. Bioorganic & Medicinal Chemistry Letters |
| Sólyomváry A, Alberti Á, Darcsi A, et al. (2017) Optimized conversion of antiproliferative lignans pinoresinol and epipinoresinol: Their simultaneous isolation and identification by centrifugal partition chromatography and high performance liquid chromatography. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 1052: 142-149 |
| Kenessey I, Kói K, Horváth O, et al. (2016) KRAS-mutation status dependent effect of zoledronic acid in human non-small cell cancer preclinical models. Oncotarget |
| Garamvölgyi R, Dobos J, Sipos A, et al. (2016) Design and synthesis of new imidazo[1,2-a]pyridine and imidazo[1,2-a]pyrazine derivatives with antiproliferative activity against melanoma cells. European Journal of Medicinal Chemistry. 108: 623-43 |
| Garay T, Molnár E, Juhász É, et al. (2015) Sensitivity of Melanoma Cells to EGFR and FGFR Activation but Not Inhibition is Influenced by Oncogenic BRAF and NRAS Mutations. Pathology Oncology Research : Por |